Skip to content

Clinical trials

Phase 2 Acquired Immunodeficiency Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 2 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20094
20102
20111
20131
20141
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare6
Tibotec Pharmaceuticals, Ireland3
Alexion Pharmaceuticals, Inc.1
Bayer1
GlaxoSmithKline1
Janssen-Cilag International NV1
National Institute of Allergy and Infectious Diseases (NIAID)1
Pfizer1
Rockefeller University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome16
HIV Infections9
Infections6
AIDS-Related Opportunistic Infections1
Cardiovascular Diseases1
Embolism1
Embolism and Thrombosis1
Immunologic Deficiency Syndromes1
Lung Diseases1
Pneumonia, Pneumocystis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.